Effect of Pharmacist Participation in Multidisciplinary Team for Home Visit on Blood Pressure and Drug Adherence of Stroke Patients
Main Article Content
Abstract
Objective: To determine the impact of pharmacist participation in multidisciplinary team for home visit on blood pressure and adherence to antihypertensive drugs of stroke patients. Methods: The study participants included 34 patients with a history of stroke who had previously received home visit from multidisciplinary team without a pharmacist as a team member. A quasi-experimental study without a control group was conducted to compare blood pressures and adherence to antihypertensive drugs before and after pharmacists’ participation in home visits with other health care professionals. Each patient was visited once a month for a total of 3 months from December 2014 to February 2015. The pharmacists provided information to the patients or caretakers on indications of each medication, the beneficial effects of blood pressure control to prevent stroke recurrence, how to manage timing of drug administration, and other advices on medication-related problems or any issues concerned by the patients or caregivers. Blood pressure at each visit was measured with an electronic sphygmomanometer. Adherence to antihypertensive drugs was measured by pill-count method. Results: Compared to that on the first visit (baseline measurement), systolic blood pressure at the third visit decreased from 147.59±5.67 to 140.26±7.61 mm Hg (P<0.01), diastolic blood pressure decreased from 90.24±8.81 to 86.03±7.55 mm Hg (P=0.01), and adherence to antihypertensive drugs increased from 80.43±17.01% to 89.69±9.67% (P<0.01). Conclusion: Pharmacist participation in multidisciplinary team for home visit of stroke patients leads to a significant decrease in systolic and diastolic blood pressure as well as increased adherence to antihypertensive drug use. Thus, pharmacist participation in multidisciplinary team for home visit should be encouraged to improve quality of care among this group of patients.
Article Details
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
2. Burden of Disease Thailand. The burden of disease and injury of Thailand's population 2011. Bangkok: Veterans' Organizations Publisher; 2014.
3. Kerman WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 2160-236.
4) Chambers JA, O’Carroll RE, Hamilton B, Whittaker J, Johnston M, Sudlow C, et al. Adherence to medication in stroke survivors: A qualitative comparison of low and high adherers. Br J Health Psychol 2011; 16: 592–609.
5) Allen KR, Hazelett S, Jarjoura D, Wickstrom GC, Hua K, Weinhardt J, et al. Effectiveness of a postdischarge care management model for stroke and transient ischemic attack: A randomized trial. J Stroke Cerebrovasc Dis 2002; 11: 88-98.
6) The American Society of Health-System Pharmacists. ASHP guidelines on the pharmacist’s role in home care. Am J Health Syst Pharm 2000; 57: 1252-7.
7) Catania PN. What is the role of the pharmacist in home care? Home Care Provid 1997; 2: 229-31.
8) Public Health Nursing Division. Home Health Care. Bangkok: Health Department of Bangkok Metropolitan Administration; 2012.
9) Nisittra P. Effects of discharge counseling and home-based interventions provided by pharmacist among elderly patients [dissertation]. Khon Kaen: Khon Kaen University; 2007.
10) Unwin BK, Jerant AF. The home visit. Am Fam Physician 1999;60:1481-8.
11) Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Adherence to hospital discharge medication in patients with ischemic stroke: A prospective, interventional 2-phase study. Stroke 2012; 44: 522-4.
12) Souter C, Kinnear A, Kinnear M, Mead G. Optimisation of secondary prevention of stroke: A qualitative study of stroke patients’ beliefs, concerns and difficulties with their medicines. Int J Pharm Pract 2014; 22: 424–32.
13) Lawes CMM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: An overview of published reviews. Stroke 2004;35: 1024-33.
14) Hanchaiphiboolkul S, Poungvarin N, Nidhinandana S, Suwanwela NC, Puthkhao P, Towanabut S, et al. Prevalence of stroke and stroke risk factors in Thailand: Thai Epidemiologic Stroke (TES) study. J Med Assoc Thai. 2011; 94: 427-36.
15) Sathirapanya C, Sathirapanya P, Trichan J. Prevalence, risk factors of stroke and post stroke depression in Phatthalung Province: A cross sectional study. Songklanagarind Medical Journal 2014; 32: 275-82.